1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market By Deployment
4.3.2 Market By Application
4.3.3 Market By End-User
4.3.4 Market Segmentation By Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Technological Advances In Precision Medicine Delivery
8.2 Increased Adoption Of Cloud-Based Platforms
8.3 Emergence Of Local & Regional Start-UPS
8.4 Artificial Intelligence In Precision Medicine
9 Market Growth Enablers
9.1 High Prevalence Of Cancer, Genetic, & Rare Diseases
9.2 Increased Partnerships Among Software & Pharmaceutical Companies
9.3 Paradigm Shift Toward Tailored Disease Treatment
10 Market Growth Restraints
10.1 High R&D & Implementation Cost Of Precision Medicine
10.2 Dearth Of Skilled Professionals
10.3 Lack Of Security & Storage For Large Volumes Of Sequenced Data
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Geography Insights
11.2.2 Deployment Insights
11.2.3 Application Insights
11.2.4 End-User Insights
11.3 Five Forces Analysis
11.3.1 Threat Of New Entrants
11.3.2 Bargaining Power Of Suppliers
11.3.3 Bargaining Power Of Buyers
11.3.4 Threat Of Substitutes
11.3.5 Competitive Rivalry
12 Deployment
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 On-Premise
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Market By Geography
12.4 Cloud
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Market By Geography
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Precision Oncology
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Market By Geography
13.4 Pharmacogenomics
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market By Geography
13.5 Rare Disease
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Market By Geography
13.6 Others
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Market By Geography
14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Healthcare Providers
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market By Geography
14.4 Research Labs
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market By Geography
14.5 Pharma & Biotech Companies
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Market By Geography
15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Deployment
16.3.1 Market Size & Forecast
16.4 Application
16.4.1 Market Size & Forecast
16.5 End-User
16.5.1 Market Size & Forecast
16.6 Key Countries
16.6.1 US: Market Size & Forecast
16.6.2 Canada: Market Size & Forecast
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Deployment
17.3.1 Market Size & Forecast
17.4 Application
17.4.1 Market Size & Forecast
17.5 End-User
17.5.1 Market Size & Forecast
17.6 Key Countries
17.6.1 Germany: Market Size & Forecast
17.6.2 France: Market Size & Forecast
17.6.3 UK: Market Size & Forecast
17.6.4 Italy: Market Size & Forecast
17.6.5 Spain: Market Size & Forecast
18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Deployment
18.3.1 Market Size & Forecast
18.4 Application
18.4.1 Market Size & Forecast
18.5 End-User
18.5.1 Market Size & Forecast
18.6 Key Countries
18.6.1 China: Market Size & Forecast
18.6.2 Japan: Market Size & Forecast
18.6.3 India: Market Size & Forecast
18.6.4 Australia: Market Size & Forecast
18.6.5 South Korea: Market Size & Forecast
19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Deployment
19.3.1 Market Size & Forecast
19.4 Application
19.4.1 Market Size & Forecast
19.5 End-User
19.5.1 Market Size & Forecast
19.6 Key Countries
19.6.1 Brazil: Market Size & Forecast
19.6.2 Mexico: Market Size & Forecast
20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Deployment
20.3.1 Market Size & Forecast
20.4 Application
20.4.1 Market Size & Forecast
20.5 End-User
20.5.1 Market Size & Forecast
20.6 Key Countries
20.6.1 Turkey: Market Size & Forecast
20.6.2 Saudi Arabia: Market Size & Forecast
21 Competitive Landscape
21.1 Competition Overview
22 Key Company Profiles
22.1 ACCESSDX LABORATORY
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 FABRIC GENOMICS
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 FOUNDATION MEDICINE
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 INTEL
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 IBM
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
22.6 SYAPSE
22.6.1 Business Overview
22.6.2 Product Offerings
22.6.3 Key Strategies
22.6.4 Key Strengths
22.6.5 Key Opportunities
23 Other Prominent Vendors
23.1 GENOMONCOLOGY
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 KONINKLIJKE PHILIPS
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 LIFEOMIC
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 NANTHEALTH
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 PHENOTIPS
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 PIERIANDX
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 QIAGEN
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 ROPER TECHNOLOGIES
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 SOPHIA GENETICS
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 TRANSLATIONAL SOFTWARE
23.10.1 Business Overview
23.10.2 Product Offerings
24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations
25 Quantitative Summary
25.1 Market By Geography
25.1.1 North America: By Deployment
25.1.2 North America: By Application
25.1.3 North America: By End-User
25.1.4 Europe: By Deployment
25.1.5 Europe: By Application
25.1.6 Europe: By End-User
25.1.7 APAC: By Deployment
25.1.8 APAC: By Application
25.1.9 APAC: By End-User
25.1.10 Latin America: By Deployment
25.1.11 Latin America: By Application
25.1.12 Latin America: By End-User
25.1.13 Middle East & Africa: By Deployment
25.1.14 Middle East & Africa: By Application
25.1.15 Middle East & Africa: By End-User
25.2 Deployment
25.2.1 On-Premises
25.2.2 Cloud
25.3 Application
25.3.1 Precision Oncology
25.3.2 Pharmacogenomics
25.3.3 Rare Diseases
25.3.4 Others
25.4 End-User
25.4.1 Healthcare Facilities
25.4.2 Research Labs
25.4.3 Pharma & Biotech Companies
26 Appendix
26.1 Abbreviations